DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Market Event Recap: FDA Ad Com Meeting to Discuss Cordis’ INCRAFT Stent Graft System


The FDA Circulatory System Devices Panel met on June 12, 2018 to provide advice, make recommendations, and vote on the premarket approval application by Cordis for its INCRAFT Stent Graft System. DRG Medtech Analyst Aditi Chadha has weighed in on this conversation to provide insight on Cordis’ current place in the market and what a positive decision means for the industry.